A Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy for Treatment-Resistant Depression
Author(s) -
Stuart J. Eisendrath,
Erin Gillung,
Kevin Delucchi,
Zindel V. Segal,
J. Craig Nelson,
L. Alison McInnes,
Daniel H. Mathalon,
Mitchell D. Feldman
Publication year - 2016
Publication title -
psychotherapy and psychosomatics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.531
H-Index - 98
eISSN - 1423-0348
pISSN - 0033-3190
DOI - 10.1159/000442260
Subject(s) - mindfulness based cognitive therapy , randomized controlled trial , medicine , depression (economics) , cognitive therapy , pharmacotherapy , mindfulness , anxiety , adverse effect , treatment resistant depression , major depressive disorder , psychology , psychiatry , clinical psychology , mood , economics , macroeconomics
Due to the clinical challenges of treatment-resistant depression (TRD), we evaluated the efficacy of mindfulness-based cognitive therapy (MBCT) relative to a structurally equivalent active comparison condition as adjuncts to treatment-as-usual (TAU) pharmacotherapy in TRD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom